Media center | Innate Pharma

ANKET: Our NK cell engager platform
Thu, 06/10/2021 - 07:00

Click here to learn more about ANKET^TM
- Read more about ANKET: Our NK cell engager platform
Interview of Eric Vivier “The new generation of NK cell therapies”
Fri, 02/05/2021 - 08:00

Interview Eric Vivier "The new generation of NK cell therapies"
- Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
Nasdaq #BehindTheBell (October 17, 2019)
Wed, 10/30/2019 - 09:45
- Read more about Nasdaq #BehindTheBell (October 17, 2019)
Nasdaq Closing Bell Ceremony (October 17, 2019)
Fri, 10/18/2019 - 09:30
- Read more about Nasdaq Closing Bell Ceremony (October 17, 2019)
CellPress : Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity | Eric Vivier
Thu, 05/30/2019 - 10:30
- Read more about CellPress : Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity | Eric Vivier

Company
Science
Products
- Pipeline overview
- Clinical trials
- ------------------
- Lacutamab
- Monalizumab
- IPH5201
- IPH5301
- IPH6101
- IPH62
- IPH6401
- IPH6501
Partnering
Investors
Media
Careers